| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate |
2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c78242a90ceadb1effdba7bee673f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb1b1a43664d47cbf5eda0b7619d3dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6582a1c726f4ed70db235e8ba3ad5dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d881f83adeccd6edb47c123c81690d6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19757a9955678ca6ceb09702bc76dd35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ff81a97039649ee89b0c8072f1bb59 |
| publicationDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107636009-A |
| titleOfInvention |
Glucagon derivatives with improved stability |
| abstract |
The present invention relates to a novel glucagon-derived peptide, and a composition for preventing or treating hypoglycemia containing the novel glucagon-derived peptide as an active ingredient. The glucagon derivatives according to the present invention have improved physical properties due to changes in the isoelectric point (pI) while being able to secure activity on glucagon receptors, thus improving patient compliance when used as hypoglycemic agents and is also suitable for combined administration with other anti-obesity agents. Therefore, the glucagon derivatives according to the present invention can be effectively used for the prevention and treatment of hypoglycemia or obesity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108025041-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836486-A |
| priorityDate |
2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |